For instance, E-selectin has been shown to be a key receptor in leukemia [24,25], myeloma [23], as well as in solid tumors such as pancreatic [26,27,28], prostate [29,30], colon [31,32] and breast [33,34,35] cancer cells. Here, SELE is linked to cancer.